Fortis Healthcare (India) is currently trading at Rs. 107.75, up by 3.15 points or 3.01% from its previous closing of Rs. 104.60 on the BSE.
The scrip opened at Rs. 108.00 and has touched a high and low of Rs. 108.40 and Rs. 106.20 respectively. So far 30,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 171.50 on 27-Jul-2011 and a 52 week low of Rs. 81.00 on 28-Dec-2011.
Last one week high and low of the scrip stood at Rs. 108.75 and Rs. 99.70 respectively. The current market cap of the company is Rs. 4,365.00 crore.
The promoters holding in the company stood at 81.48% while Institutions and Non-Institutions held 6.13% and 12.39% respectively.
Fortis Healthcare (India) offshore subsidiary, Fortis Healthcare Singapore has acquired 85% stake in RadLink-Asia (RadLink), an outpatient diagnostic and molecular imaging chain in Singapore, for a purchase consideration of S$62.9 million.
This transaction provides Fortis Healthcare a strong foothold in the premium diagnostics and molecular imaging segment in one of Southeast Asia's most attractive markets besides providing a complementary platform to its upcoming specialty hospital on Adam Road in Singapore.
Radlink has four main business segments; diagnostic imaging, molecular imaging, cyclotron (radio-isotopes manufacturing) and GP clinics.
Fortis Healthcare (India) is committed to clinical excellence and patient-centric healthcare, which is manifest in hospital design, patient services, medical programmes and the compassionate approach of medical and non-medical hospital staff. Fortis commissioned its first hospital in 2001 at Mohali, near Chandigarh, and has expanded its operations to become a network with an over 10,000 bed capacity across 68 hospitals.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7248.75 |
| Max Healthcare Inst | 1166.60 |
| Narayana Hrudayalay | 1286.30 |
| Aster DM Healthcare | 486.85 |
| Global Health | 1098.95 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
